Literature DB >> 284412

Regulation of macrophage migration by products of the complement system.

C Bianco, O Götze, Z A Cohn.   

Abstract

Agents formerly shown to induce rapid macrophage spreading were examined for their ability to modify the migration of macrophages in the capillary tube assay. Products of the activation of the contact phase of blood coagulation as well as the purified component Bb, the large cleavage fragment of factor B of the alternative complement pathway produced a dose-dependent inhibition of migration. In addition, inflammatory macrophages elicited with either a lipopolysaccharide endotoxin or thioglycollate medium exhibited rapid spreading and inhibited migration, whereas resident cells did not. A close correlation existed, therefore, between enhanced spreading and inhibited migration under both in vitro induced and in vivo situations. Cleavage products of component C5 of the classical complement pathway enhanced macrophage migration and did not alter spreading. In mixtures of C5 cleavage products and Bb, the predominant peptide determined the outcome of the reaction. Factor B, a normal secretory product of macrophages, may represent a common substrate for several of the proteases that induce spreading, inhibit migration, and lead to the generation of the enzymatically active fragment Bb.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 284412      PMCID: PMC383083          DOI: 10.1073/pnas.76.2.888

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  Mouse factor B of the alternative pathway of complement activation. I. Purification, characterization, and functional behavior.

Authors:  D Bitter-Suermann; R Burger; V Brade; U Hadding
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

2.  The C3-activator system: an alternate pathway of complement activation.

Authors:  O Götze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

3.  In vitro synthesis of factor B of the alternative pathway of complement activation by mouse peritoneal macrophages.

Authors:  C Bentley; D Bitter-Suermann; U Hadding; V Brade
Journal:  Eur J Immunol       Date:  1976-06       Impact factor: 5.532

Review 4.  The alternative pathway of complement activation.

Authors:  O Götze; H J Müller-Eberhard
Journal:  Adv Immunol       Date:  1976       Impact factor: 3.543

Review 5.  In vitro approaches to the mechanism of cell-mediated immune reactions.

Authors:  B R Bloom
Journal:  Adv Immunol       Date:  1971       Impact factor: 3.543

6.  Generation of macrophage migration inhibitory activity by plasminogen activators.

Authors:  R O Roblin; M E Hammond; N D Bensky; A M Dvorak; H F Dvorak; P H Black
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

7.  Production of migration inhibition factor (MIF) and an inducer of plasminogen activator (IPA) by subsets of T cells in MLC.

Authors:  W Newman; S Gordon; U Hämmerling; A Senik; B R Bloom
Journal:  J Immunol       Date:  1978-03       Impact factor: 5.422

8.  The induction of macrophage spreading: role of coagulation factors and the complement system.

Authors:  C Bianco; A Eden; Z A Cohn
Journal:  J Exp Med       Date:  1976-12-01       Impact factor: 14.307

9.  A plasmin-split fragment of C'3 as a new chemotactic factor.

Authors:  P A Ward
Journal:  J Exp Med       Date:  1967-08-01       Impact factor: 14.307

10.  DISTRIBUTION, INHERITANCE, AND PROPERTIES OF AN ANTIGEN, MUB1, AND ITS RELATION TO HEMOLYTIC COMPLEMENT.

Authors:  B CINADER; S DUBISKI; A C WARDLAW
Journal:  J Exp Med       Date:  1964-11-01       Impact factor: 14.307

View more
  19 in total

Review 1.  Synthesis of complement by macrophages and modulation of their functions through complement activation.

Authors:  H P Hartung; U Hadding
Journal:  Springer Semin Immunopathol       Date:  1983

Review 2.  Complement components in relation to macrophage function.

Authors:  H P Hartung; U Hadding
Journal:  Agents Actions       Date:  1983-08

3.  Plasma membrane polypeptides of resident and activated mouse peritoneal macrophages.

Authors:  H L Yin; S Aley; C Bianco; Z A Cohn
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

4.  Bb fragment of bovine complement factor B: stimulation of the oxidative burst in bovine monocytes.

Authors:  M S Sethi; H Tabel
Journal:  Can J Vet Res       Date:  1990-10       Impact factor: 1.310

5.  Induction of immune cytolysis: tumor-cell killing by complement is initiated by covalent complex of monoclonal antibody and stable C3/C5 convertase.

Authors:  C W Vogel; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

6.  Fragment Bb in amniotic fluid: evidence for complement activation by the alternative pathway in women with intra-amniotic infection/inflammation.

Authors:  Edi Vaisbuch; Roberto Romero; Offer Erez; Shali Mazaki-Tovi; Juan Pedro Kusanovic; Kusanovic Juan Pedro; Eleazar Soto; Francesca Gotsch; Zhong Dong; Tinnakorn Chaiworapongsa; Sun Kwon Kim; Pooja Mittal; Percy Pacora; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2009-10

7.  Delayed hypersensitivity reactions to Listeria monocytogenes in rats decomplemented with cobra factor and in C5-deficient mice.

Authors:  T W Jungi; M B Pepys
Journal:  Immunology       Date:  1981-06       Impact factor: 7.397

8.  Activation of bovine monocytes and neutrophils by the Bb fragment of complement factor B: demonstration by the uptake of 3H-deoxyglucose.

Authors:  M S Sethi; H Tabel; V Misra
Journal:  Can J Vet Res       Date:  1990-01       Impact factor: 1.310

9.  Effect of Micropolyspora faeni cells and cell wall fractions on rabbit alveolar macrophages.

Authors:  D B Learn; I S Snyder
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

10.  Circulating monocyte migration inhibitory factor in serum of Graves' ophthalmopathy patients: a parameter for disease activity?

Authors:  R van der Gaag; L Broersma; M P Mourits; L Koornneef; W M Wiersinga; M P Prummel; A Berghout
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.